Aligned to that, elevated S100A8/A9 levels are observed in the serum and sputum of asthmatic patients, particularly during episodes of exercise-induced bronchoconstriction (47), without any difference between the subgroups of asthma or compared to COPD (48, 49). Here, S100A8 is linked to chronic obstructive pulmonary disease.